Chidozie Ojobor is a scientist-entrepreneur and is the cofounder and Chief Science Officer at Vitract, a microbiome company providing comprehensive and accessible gut testing to clinicians to improve the gut health of their clients/patients. Chidozie started his academic career in virus research, where he studied rotaviruses that cause gastroenteritis in children under the age of 5. Afterwards, he completed his PhD in Molecular Genetics at the University of Toronto where he was genetically engineering bacteriocins as novel therapeutic tools against bacterial pathogens. Chidozie developed interest in the microbiome during his doctoral research when he realized that the therapeutic entity he was developing had the potential to manipulate complex biological ecosystems such as the gut microbiome. After his PhD, he then cofounded Vitract, a microbiome company that provides insight into gut health based on the composition of gut bacteria in stool samples. Chidozie and his team are leveraging molecular sequencing techniques, AI and the robust body of scientific evidence associating the gut and overall health, to build comprehensive gut health solutions for Canadians and Americans. Get 25$ off your Vitract gut test with code FARMTOFUTURE at https://vitract.com/ Scientific studies: Experimental mouse study on maternal glyphosate exposure and ASD:  https://pubmed.ncbi.nlm.nih.gov/32398374/ Epidemiological study on antibiotic use in infants and ASD:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164008/ C-section births and ASDHuman cohort study involving 5 million births https://pubmed.ncbi.nlm.nih.gov/28017932/ Experimental study in mice https://pubmed.ncbi.nlm.nih.gov/33903690/ Connect with Vitract: WebsiteInstagramLinkedInFacebookConnect with Jane Z. on Instagram at @farm.to.future